Literature DB >> 34718525

A VIRTUAL Sleep Apnoea management pathway For the work-up of Atrial fibrillation patients in a digital Remote Infrastructure: VIRTUAL-SAFARI.

Dominique V M Verhaert1,2, Konstanze Betz1, Monika Gawałko1,3,4, Astrid N L Hermans1, Nikki A H A Pluymaekers1, Rachel M J van der Velden1, Suzanne Philippens1, Bianca Vorstermans1, Sami O Simons5, Dennis W den Uijl1, Sevasti-Maria Chaldoupi1, Justin G L M Luermans1, Sjoerd W Westra2, Theo Lankveld1, Kadhim Kadhim6, Jean-Louis Pepin7, Reindert P van Steenwijk8, Bernard Hol8, Ulrich Schotten1, Prashanthan Sanders6, Kevin Vernooy1,2, Jeroen M Hendriks6,9, Dominik Linz1,2,6,10.   

Abstract

AIMS: In atrial fibrillation (AF) patients, untreated sleep-disordered breathing (SDB) is associated with lower success rates of rhythm control strategies and as such structured SDB testing is recommended. Herein, we describe the implementation of a virtual SDB management pathway in an AF outpatient clinic and examine the utility and feasibility of this new approach. METHODS AND
RESULTS: Prospectively, consecutive AF patients accepted for AF catheter ablation procedures without previous diagnosis of SDB were digitally referred to a virtual SDB management pathway and instructed to use WatchPAT-ONE (ITAMAR) for one night. Results were automatically transferred to a virtual sleep laboratory, upon which a teleconsultation with a sleep physician was planned. Patient experience was measured using surveys. SDB testing was performed in 119 consecutive patients scheduled for AF catheter ablation procedures. The median time from digital referral to finalization of the sleep study report was 18 [11-24] days. In total, 65 patients (55%) were diagnosed with moderate-to-severe SDB. Patients with SDB were prescribed more cardiovascular drugs and had higher body mass indices (BMI, 29 ± 3.3 vs. 27 ± 4.4kg/m2, P < 0.01). Patients agreed that WatchPAT-ONE was easy to use (91%) and recommended future use of this virtual pathway in AF outpatient clinics (86%). Based on this remote SDB testing, SDB treatment was recommended in the majority of patients.
CONCLUSION: This novel virtual AF management pathway allowed remote SDB testing in AF outpatient clinics with a short time to diagnosis and high patient satisfaction. Structured SDB testing results in a high detection of previously unknown SDB in AF patients scheduled for AF ablation. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Ablation; Ambulatory monitoring; Atrial fibrillation; Integrated care; Sleep apnoea; Sleep-disordered breathing; mHealth

Mesh:

Year:  2022        PMID: 34718525     DOI: 10.1093/europace/euab229

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  3 in total

1.  Impact of undiagnosed obstructive sleep apnea on atrial fibrillation recurrence following catheter ablation (OSA-AF study).

Authors:  John de Heide; Danielle B M Kock-Cordeiro; Rohit E Bhagwandien; Mark G Hoogendijk; Koen C van der Meer; Sip A Wijchers; Tamas Szili-Torok; Felix Zijlstra; Mattie J Lenzen; Sing-Chien Yap
Journal:  Int J Cardiol Heart Vasc       Date:  2022-03-24

2.  Undiagnosed sleep apnea in patients with atrial fibrillation: An underutilized opportunity for antiarrhythmic management.

Authors:  Maartje J M Hereijgers; Konstanze Betz; Sami O Simons; Dominik Linz
Journal:  Int J Cardiol Heart Vasc       Date:  2022-05-16

3.  Rationale and Design of the ISOLATION Study: A Multicenter Prospective Cohort Study Identifying Predictors for Successful Atrial Fibrillation Ablation in an Integrated Clinical Care and Research Pathway.

Authors:  Dominique V M Verhaert; Dominik Linz; Sevasti Maria Chaldoupi; Sjoerd W Westra; Dennis W den Uijl; Suzanne Philippens; Mijke Kerperien; Zarina Habibi; Bianca Vorstermans; Rachel M A Ter Bekke; Rypko J Beukema; Reinder Evertz; Martin E W Hemels; Justin G L M Luermans; Randolph Manusama; Theo A R Lankveld; Claudia A J van der Heijden; Elham Bidar; Ben J M Hermans; Stef Zeemering; Geertruida P Bijvoet; Jesse Habets; Robert J Holtackers; Casper Mihl; Robin Nijveldt; Vanessa P M van Empel; Christian Knackstedt; Sami O Simons; Wolfgang F F A Buhre; Jan G P Tijssen; Aaron Isaacs; Harry J G M Crijns; Bart Maesen; Kevin Vernooy; Ulrich Schotten
Journal:  Front Cardiovasc Med       Date:  2022-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.